IMMUNOSUPPRESSION IN IMMUNOTOXIN BASED HUMAN THERAPY

摘要

Novel methods for immunotoxin based human therapy in which immunosuppressive amounts of cyclophosphamide, azathioprine, cyclosporine or 6-mercaptopurine are co-administered to enhance the long term effectiveness of the immunotoxin and diminish complications from the patient's immune response to the immunotoxin. The cyclophosphamide may be used in combination with other agents in managing the patient's treatment for various diseases, such as cancers.